Biopharma Layoff Tracker 2024: CureVac, Takeda, Aerovate and More Cut Staff

1. CureVac Layoffs: CureVac has cut 30% of its roles, joining a growing list of biopharma companies downsizing in 2024.
2. Takeda Layoffs: Takeda has announced plans to lay off over 1,300 employees so far in 2024, including 186 in Massachusetts and hundreds at two R&D manufacturing facilities.
3. Industry Trends: Biotech and pharma layoffs in 2023 totaled at least 10,000 jobs, and 2024 has seen more than 14,000 positions cut so far, with no signs of slowing down.
4. Other Layoffs: Companies like GeNeuro, G1 Therapeutics, eFFECTOR Therapeutics, Barinthus Biotherapeutics, Genentech, Novartis, Sanofi, Boehringer Ingelheim, Amylyx Pharmaceuticals, Carisma Therapeutics, and many others have also announced significant layoffs in 2024.
5. Reasons for Layoffs: Companies cite various reasons, including restructuring, cost-cutting, and strategic reorganization, often in response to market pressures and the need to conserve cash.